The Swedish Medical Products Agency (MPA; Läkemedelsverket) carried out a study in 2020-2021 regarding the feasibility of patient-centric, decentralized, and virtual clinical trials. Decentralized interventional clinical trials collect data remotely, usually with the help of digital tools. The study by the Swedish MPA concluded that there are no formal obstacles, associated with the regulations included in the MPA’s assignment, to conducting clinical drug trials with decentralized elements. Learn more in English or Swedish.
Examples of decentralized elements include remote electronic consent, at-home sampling, remote study visits, as well as medical devices to capture treatment compliance and possible side effects.
The Swedish MPA is offering a webinar to discuss different examples of decentralized and virtual intervention trials on June 9th (9:30-12pm Swedish time). The webinar will be held in Swedish, and no pre-registration is required. View meeting agenda and meeting link.
Don’t miss this chance to hear about real-life examples, experiences, and learnings about decentralized trials from Sponsors and study personnel.
If you need support planning or carrying out a clinical trial, contact Scandinavian CRO to find out about our clinical services.
